Trade ALPMY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) is trading at US$14.20, down 0.28% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$26.97B. Over the past 52 weeks, ALPMY has traded between US$10.03 and US$17.35. On Syfe you can trade ALPMY with $0 commission and add it to your watchlist.
| Previous close | US$14.24 |
|---|---|
| Market cap | US$26.97B |
| P/E ratio | 11.31 |
| 52-week range | US$10.03 – US$17.35 |
| Dividend yield | 2.85% |
| Volume | 95.02K |
| Exchange | US |
Astellas Pharma Inc Unsponsored ADR (Japan)
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) stock is trading at US$14.20, -0.28% from the previous close of US$14.24.
The market cap for Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) stock is approximately US$26.97B.
The price-to-earnings ratio for Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) is 11.31, based on the latest reported earnings.
The 52-week high for Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) stock is US$17.35.
The 52-week low for Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) stock is US$10.03.
Yes, Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) pays a dividend. The trailing 12-month dividend yield is 2.85%.
Stay on top of ALPMY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
